Multiple Sclerosis: Special Populations & Considerations
- Continuing Education
Start Today Register and begin immediately.
Address complex multiple sclerosis challenges with this focused session that equips professionals with current insights, practical strategies, and innovative tools to improve care across diverse patient populations.
- Online; Self-Paced
This course is offered on demand and participants progress through the materials at their own pace.
Earn up to:
1.75 AMA PRA Category 1 Credit(s) ™
1.75 ANCC contact hours
1.75 Risk Management Study credits
View All
On This Page
Overview
The multiple sclerosis (MS) and neuroimmunology field enjoyed a recent explosion of effective therapeutic options that are used to manage patients with this chronic and previously frequently disabling condition. While there is no cure for MS, disease modifying treatments (DMTs) reduce clinical and radiographic disease activity and delay MS progression to neurologic disability. However, with the increase in therapeutic options comes complexity of choices, and a true opportunity to practice personalized medicine, selecting the most appropriate, effective, and safe treatment choice for the patients. The need to initiate, stop or change DMTs depends on patients’ previous treatments, disease stability or progression, family planning needs, age, gender, and availability of therapies within their health insurance coverage. Special populations, such as children, older adults, and women in the reproductive planning phases of their lives have additional treatment considerations. Managing MS symptoms is important aspect of comprehensive MS care, as is non-pharmacologic approach to rehabilitation improvement of the overall quality of life. The research efforts in basic and clinical neuroimmunology have expanded our understanding of MS pathogenesis. Recent important contributions have focused on the effects of genetic predisposition and the microbiota on disease onset and progression, and the novel neuroimaging techniques and biomarker predictors of disease outcomes.
This CME program accredited by Harvard Medical School will present the most up-to-date clinical and research information relevant to health care providers who treat patients with multiple sclerosis. Through this initiative, participants will advance their knowledge and competence to provide excellent clinical care to patients with MS and will thoroughly improve their understanding of the recent and important research trends and results in this rapidly developing field.
This course contains four sessions. Learners have the option of registering for the full course or registering for the four sessions individually.
Full Course:
Session information:
Session 1: Multiple Sclerosis and Demyelinating Disorders: Differential Diagnosis
Session 2: Multiple Sclerosis Therapeutics
Session 3: Ancillary Assessment Tools and Techniques in MS
Session 4: Multiple Sclerosis: Special Populations and Considerations
Learning Objectives
- Review the diagnosis and treatment of the following conditions: acute disseminated encephalomyelitis (ADEM), pediatric multiple sclerosis, MOG antibody disease in children (MOGAD), and neuromyelitis spectrum disorders in children (NMOSD).
- Describe the relationship between MS and pregnancy, including obstetrical and neurologic outcomes in the peri-partum period.
- Identify how the gut microbiome may contribute to MS.
- Define the social determinants of health (SDOH).
- Review COVID-19 infection outcomes in patients with MS (pwMS).
- Define telehealth and its key components.
- Identify the different modalities of telehealth in the context of MS.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Brigham and Women's Hospital.
Participant Types
Nurse Practitioners, Nurses, Others, Physician Assistants, Primary Care Physicians, Specialty Physicians, Social Workers, and Clinician-Scientists
Schedule
All agenda sessions are in Eastern Time.
TBD
Module Overview: Special Populations and Considerations - Chair: Tanuja Chitnis
TBD
Module 1: Pediatric MS & Related Disorders
Tanuja Chitnis
TBD
Module 2: Pregnancy and MS
Maria Houtchens
TBD
Module 3: The Microbiome and Diet in MS
Laura Cox
TBD
Module 4: Health Disparities in MS
Farrah Mateen
TBD
Module 5: COVID-19 and MS
Sarah Conway
TBD
Module 6: Telemedicine for those with MS
Marcelo Matiello
TBD
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Maria Houtchens, MD, MSc
Course Director
- Associate Professor of Neurology, Harvard Medical School
- Neurologist, Brigham and Women's Hospital
Eric Klawiter, MD, MSc
Course Director
- Associate Professor of Neurology, Harvard Medical School
- Associate Neurologist, Massachusetts General Hospital
Tanuja Chitnis, MD, MA, FAAN
Course Director
- Professor of Neurology, Harvard Medical School
- Cindy Larsen Chugg Distinguished Chair in Neurology & Senior Neurologist, Brigham and Women's Hospital
Rohit Bakshi, MD
Shamik Bhattacharyya, MD
Gauruv Bose, MD
Sarah Conway, MD
Laura Cox, PhD
Kristin Galetta, MD
Tamara Kaplan, MD
Michael Levy, MD
Farrah Mateen, MD
Marcelo Matiello, MD
Christopher Severson, MD
Tarun Singhal, MD
Lynn Stazzone, NP
Jonathan Zurawski, MD
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. At the end of the registration process, a $5 processing fee will be added to your registration. Because online course materials can be accessed immediately, refunds are not permitted.
Learners have the option of registering for the full course (all four sessions) or purchasing individual sessions.
| Role | Standard Price |
|---|---|
| Physician (MD/DO) | $45.00 |
| Nurse (RN/APRN) | $30.00 |
| Industry | $88.00 |
| PA | $30.00 |
| Resident/Fellow | $30.00 |
| Social Worker | $30.00 |
| Allied Health Professional / Other | $30.00 |
Medical Students with confirmation of student status: $13. Please email mseducation@bwh.harvard.edu for more information.
Accreditation
The Harvard Medical School designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 1.75 ANCC contact hours.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 1.75 credits of Risk Management Study.
Please check your individual state licensing board requirements before claiming these credits.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.